P2RX7 and breast carcinoma: Studies have confirmed that P2X7 is highly expressed in some tumors, such as prostate (68), breast cancer and skin cancer (69, 70), neuroblastoma (71), thyroid cancer (72), and B-cell chronic lymphocytic leukemia (73) (Figure 3).